Brankica Krstevska, Sasha Misevska Jovanovska, Slagjana Simeonova Krstevska, Valentina Velkoska Nakova and Vladimir Serafimoski
1. Horosz E, Bomba Opon D, Wielogos M, Szymanska M, Bartlkowink R. Effects of maternal lipids on the fetal growth in gestational diabetes. Neuro Endocrinol Lett. 2009; 30: 652–6.
2. Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakan M, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetesmellitus and control pregnancies. Diabet Med. 2011; 28: 1053–9.
3. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for
Slagjana Simeonova-Krstevska, Brankica Krstevska, Valentina Velkoska-Nakova, Marija Hadji Lega, Igor Samardjiski, Vladimir Serafimoski, Vesna Livrinova, Irena Todorovska and Aneta Sima
1. Vahratian A, Misra VK, Trudeau S, Misra DP. Prepregnancy body mass indexand gestational age-dependent changes in lipid levels during pregnancy. Obstet Gynecol. 2010; 116: 107–113.
2. Koukkou E, Watts GF, Lowy C. Serum lipid, lipoprotein and apolipoproteinchanges in gestational diabetesmellitus: a cross-sectional and prospectivestudy. J Clin Pathol. 1996; 49: 634–637.
3. Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetesmellitus: a
impact of life changes: Development of the life experiences survey. J Consult Clin Psychol. 1978; 46: 932-46.
24. Sipetic S, Vlajinac H, Marinkovi J, Kocev N, Milan B, Ratkov I, Sajic S. Stressful life events and psychological dysfunctions before the onset of type 1 diabetesmellitus. J Pediatr Endocrinol Metab. 2007; 20 (4): 527-34.
25. Schiffrin A. Psychosocial issues in pediatric diabetes. Curr Diab Rep. 2001 1(1): 33-40.
Aleksandra Janchevska, Zoran Gucev, Velibor Tasic and Momir Polenakovic
mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetesmellitus. 2007
11. American Diabetes, Association. Diagnosis and classification of diabetesmellitus. Diabetes Care. 2005; 28(1): S37–42.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 Jul; 28(7): 412-419.
13. Nolan JJ, Færch K. Estimating insulin sensitivity and
Marija Vavlukis, Biljana Zafirovska, Emilija Antova, Bekim Pocesta, Enes Shehu, Hajber Taravari, Irena Kotlar, Darko Kitanovski, Danica Petkoska, Ivan Vasilev, Filip Janusevski, Ivica Bojovski and Sashko Kedev
Disorders 2017; 16: 14.
4. Tamita K, Katayama M, Takagi T, et al. Newly diagnosed glucose intolerance and prognosis after acute myocardial infarction: comparison of post-challenge versus fasting glucose concentrations. Heart 2012; 98(11): 848-54.
5. Lazzeri C, Valente S, Chiostri M, et al. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol. 2014; 6(4): 140-7.
6. George A, Bhatia RT, Buchanan GL, et al. Impaired Glucose Tolerance or Newly Diagnosed DiabetesMellitus Diagnosed during
1. Bennett H, Knowler WC. Definition, Diagnosis and Classification of diabetesmellitus and glucose homeostasis. In: Khan R, Weir GC, King GL, Jacobson AM, Moses AC, Smith RJ editors. Joslin Diabetes Center. Boston: Lipincott Wiliams & Wilkins; 2005, p. 105-13.
2. DiabetesMellitus Complications. In: Larsen. Williams Textbook of Endocrinology. 10th ed. 2003. Available from: http://members.tripod.com/~enotes/dm_complicatio ns.htm
3. Health Intelligence: Analyzing health data, generating and communicating evidence to improve population health
Mihaela Oraviţan, Claudiu Avram, Stela Iurciuc, Petru Mergheş and Bogdan Almăjan-Guţă
This study is a part of the activities in a cross border cooperation project that has proposed the management of obesity and cardio-metabolic risk at students from Timisoara and Szeged university centres. The target group of Timisoara University Center was formed out of 600 students enrolled in the four major universities from Timisoara; target group students were questioned about their lifestyle and were evaluated anthropometric parameters, body composition and arterial stiffness; based on questionnaires was determine too the risk of developing cardiovascular disease and/or diabetes mellitus type II. Analysis of the results revealed the strong correlations between lifestyle and cardio-metabolic risk in these students.
Polyunsaturated omega-3 and omega-6 fatty acids are essential fatty acids that cannot be produced by the body itself and therefore must be provided through nutrition. Omega-6 and particularly omega-3 fatty acids have important roles in the organism, contributing to the maintenance and promotion of health. The optimal proportion of omega-6/omega-3 fatty acids is 2:1, or even better 1:1. They are involved in normal growth and development, play a role in the prevention of coronary and cardiovascular diseases, of diabetes mellitus, of arterial hypertension, arthritis and cancer. Omega-3 fatty acids mainly have an anti-inflammatory effect, but also act as hypolipidemic and antithrombotic agents. A potential role of omega-3 fatty acids is that of increasing physical performance. Their role in the physical activity refers on one side to the global health of athletes and on the other side to their anti-inflammatory effect, as high intensity physical exercise induces increased free-radical production and microtraumas, with the induction of an inflammatory status. The anti-inflammatory effect of these fatty acids manifests through an increased production of endogenous antioxidant enzymes, through decreasing the production of prostaglandins metabolites, decreasing the production of leukotriene B4, etc. They are also effective on reducing muscle pain post eccentric exercise and on decreasing the severity of bronchoconstriction induced by exercise, as well as improving pulmonary function variables. In conclusion it seems that supplementing diets with omega-3 fatty acids, apart from having benefic effects on health and on the prevention and management of certain affections, proves to be a beneficial for physical activity and athletic performance.
1. Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in managed care population. Diabetes Care. 1997; 20: 1396-1402. 1b. Berry J, Keebler Me, McGuire DK. DiabetesMellitus and Cardiovascular Disease: Pandora's Box has been opened. Herz. 2004; 29(5): 456-62.
2. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of Ischemic Stroke in Patients with Diabetes. The Greater Cincinnati/Northern Kentucky Stroke study. Diabetes care. 2005; 28: 355-359.
2b. Van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ
and the Prevention of Chronic Diseases. WHO Technical Report, Series\ 797. Geneva: World Health Organization;
19. Keenan J.M., Pins J.J., Frazel C., Moran A., Turnquist L. (2002) Oat ingestion reduces systolic and diastolic blood pressure in patients with mild or borderline hypertension: a pilot trial. J Fam Prac, 51(4):369;
20. Chandalia M., Garg A., Lutjohann D., von Bergmann K., Grundy S.M., Brinkley L.J. (2000) Beneficial effects of high dietary fiber intake in patients with type 2 diabetesmellitus. N Engl J Med, 342